Arca
Skip to content
Tools
Tools

Amicus MNC Apheresis Kit Double Needle. Component of Amicus Separator multiprocedural…

Recall Z-1254-2023, part of FDA recall event 91704. See Fenwal's company page.

Fenwal Inc started this Class II device recall on Feb 14, 2023 (voluntary: firm initiated); FDA lists it as ongoing.

  • Classification: Class II
  • Started: Feb 14, 2023
  • Status: Ongoing
  • Products in this event: 2

Why It Was Recalled

Class II

Potential for centrifuge packs to develop a stress leak for certain lots of Amicus MNC Apheresis kit and Amicus Exchange kit (Therapeutic Kits) on the Amicus Separator.

Record

Product
Amicus MNC Apheresis Kit Double Needle. Component of Amicus Separator multiprocedural apheresis platform
Quantity
1,614 units
Lots and codes
Product Code X6R2326; UDI: 04086000100144; Batch Numbers: FA22G25121, FA22H22134, FA22I26141, FA22J25225, FA22J31074. The Lot number coding system is the following: FAXXYaabbc; FA = Haina (manufacturing / production unit); XX = two digit year; Y= letter of the alphabet corresponding to the month; aa= day; bb= sequential number; c= check digit.
Distribution
Nationwide distribution. International distribution to France, Korea, Taiwan, Colombia, India, Brazil, Germany, Canada.
Recalling firm
Fenwal Inc, Lake Zurich, IL, United States
How the firm notified
Letter
FDA classified
Mar 15, 2023

Other Products in This Recall

Recall event 91704

Fenwal Inc's Other Recalls

Newest first, one product per recall event; search them all

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.